第 1 到 17 筆結果,共 17 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2019 | Synthesis and biological evaluation of anthra[1,9-cd]pyrazol-6(2H)-one scaffold derivatives as potential anticancer agents | Chen T.-C.; JIH-HWA GUH ; Hsu H.-W.; Chen C.-L.; Lee C.-C.; Wu C.-L.; Lee Y.-R.; JING-JER LIN ; Yu D.-S.; Huang H.-S. | Arabian Journal of Chemistry | 8 | 7 | |
2 | 2019 | Design, synthesis and biological evaluation of tetracyclic azafluorenone derivatives with topoisomerase I inhibitory properties as potential anticancer agents | Chen T.-C.; Yu D.-S.; Chen S.-J.; Chen C.-L.; Lee C.-C.; Hsieh Y.-Y.; Chang L.-C.; JIH-HWA GUH ; JING-JER LIN ; Huang H.-S. | Arabian Journal of Chemistry | 11 | 11 | |
3 | 2016 | Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation | Chang L.-C.; Chen T.-C.; Chen S.-J.; Chen C.-L.; Lee C.-C.; Wu S.-H.; Yen Y.; Huang H.-S.; JING-JER LIN | Oncotarget | 8 | 9 | |
4 | 2013 | Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents | Chen T.-C.; Yu D.-S.; Huang K.-F.; Fu Y.-C.; Lee C.-C.; Chen C.-L.; Huang F.-C.; Hsieh H.-H.; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 26 | 24 | |
5 | 2013 | Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology | Chen C.-L.; Chang D.-M.; Chen T.-C.; Lee C.-C.; Hsieh H.-H.; Huang F.-C.; Huang K.-F.; JIH-HWA GUH ; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 35 | 34 | |
6 | 2012 | Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones | Lee C.-C.; Huang K.-F.; Chang D.-M.; Hsu J.-J.; Huang F.-C.; Shih K.-N.; Chen C.-L.; Chen T.-C.; Chen R.-H.; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 22 | 24 | |
7 | 2012 | Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives | Lee C.-C.; Huang K.-F.; Lin P.-Y.; Huang F.-C.; Chen C.-L.; Chen T.-C.; JIH-HWA GUH ; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 27 | 23 | |
8 | 2012 | Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-lkinked aminoacyl residue derivatives | Huang F.-C.; Huang K.-F.; Chen R.-H.; Wu J.-E.; Chen T.-C.; Chen C.-L.; Lee C.-C.; Chen J.-Y.; JING-JER LIN ; Huang H.-S. | Archiv der Pharmazie | 8 | 8 | |
9 | 2010 | NSC746364, NSC746365, and NSC746366: The spectra of cytotoxicity and molecular correlates of response to telomerase activity | Huang H.-S.; Huang K.-F.; Lee C.-C.; Chen C.-L.; Li C.-L.; JING-JER LIN | Anti-Cancer Drugs | 9 | 9 | |
10 | 2009 | Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[ 1,2-d]imidazole-6,11 -dione homologues | Huang H.-S.; Chen T.-C.; Chen R.-H.; Huang K.-F.; Huang F.-C.; Jhan J.-R.; Chen C.-L.; Lee C.-C.; Lo Y.; JING-JER LIN | Bioorganic and Medicinal Chemistry | 56 | 51 | |
11 | 2009 | Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones | Shchekotikhin A.E.; Glazunova V.A.; Dezhenkova L.G.; Luzikov Y.N.; Sinkevich Y.B.; Kovalenko L.V.; Buyanov V.N.; Balzarini J.; Huang F.-C.; JING-JER LIN ; Huang H.-S.; Shtil A.A.; Preobrazhenskaya M.N. | Bioorganic and Medicinal Chemistry | 42 | 37 | |
12 | 2008 | Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives | Huang H.-S.; Huang K.-F.; Li C.-L.; Huang Y.-Y.; Chiang Y.-H.; Huang F.-C.; JING-JER LIN | Bioorganic and Medicinal Chemistry | 48 | 41 | |
13 | 2007 | Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones | Huang H.-S.; Chen I.-B.; Huang K.-F.; Lu W.-C.; Shieh F.-Y.; Huang Y.-Y.; Huang F.-C.; JING-JER LIN | Chemical and Pharmaceutical Bulletin | 48 | 44 | |
14 | 2007 | A concise paradigm for the construction of amide linker of 2,7-diamidoanthraquinone derivatives as potential telomerase inhibitors | Huang H.-S.; JING-JER LIN ; Huang K.-F.; Li C.-L. | Taiwan Pharmaceutical Journal | 2 | ||
15 | 2005 | Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones | Huang H.-S.; Chou C.-L.; Guo C.-L.; Yuan C.-L.; Lu Y.-C.; Shieh F.-Y.; JING-JER LIN | Bioorganic and Medicinal Chemistry | 34 | 31 | |
16 | 2003 | Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone | Huang H.-S.; Chiou J.-F.; Fong Y.; Hou C.-C.; Lu Y.-C.; Wang J.-Y.; Shih J.-W.; Pan Y.-R.; JING-JER LIN | Journal of Medicinal Chemistry | 63 | 52 | |
17 | 2001 | Studies on anthracenes. 1. Human telomerase inhibition and lipid peroxidation of 9-acyloxy 1,5-dichloroanthracene derivatives | Huang H.-S.; Hwang J.-M.; Jen Y.-M.; JING-JER LIN ; Lee K.-Y.; Shi C.-H.; Hsu H.-C. | Chemical and Pharmaceutical Bulletin | 26 | 22 |